Skip to Content

Enhanze SC Approval Status

  • FDA approved: No
  • Brand name: Enhanze SC
  • Generic name: recombinant human hyaluronidase
  • Company: Halozyme Therapeutics, Inc.
  • Treatment for: Drug Delivery

Enhanze SC is a local formulation of recombinant human hyaluronidase intended for use as a "spreading agent" to enhance the drug delivery of local anesthesia, contrast agents, and for subcutaneous fluid replacement (also called hypodermoclysis).

Development Status and FDA Approval Process for Enhanze SC

Mar 28, 2005Halozyme Therapeutics Files NDA for Enhanze SC

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.